Related Experiment Video
Updated: Mar 1, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Testicular cancer update
Nabil Adra1, Lawrence H Einhorn1
1Indiana University School of Medicine, Indianapolis, Indiana.
Abstract:
The advances seen in the treatment of testicular cancer are among the great achievements in modern medicine. These advances were made possible by the collaborative efforts of cancer researchers around the world. Investigators have been able to address many questions regarding the treatment of patients with disease limited to the testis, those with metastasis to the retroperitoneum only, and those with advanced metastatic disease. Questions answered include the chemotherapeutic agents to be used and in what combinations, the proper intensity of treatment and appropriate dosing, the optimal number of cycles of chemotherapy according to validated risk stratification, appropriate surgical approaches that preserve sexual function, the treatment of relapsed disease, what supportive care measures to take, and survivorship issues following treatment of testicular cancer. Today, cure is achievable in 95% of all patients with testicular cancer and 80% of those who have metastatic disease. Despite remarkable results with frontline and salvage combination chemotherapy, metastatic testicular cancer remains incurable in approximately 10% of patients, and novel treatment approaches are warranted. This review highlights past and recent discoveries in the treatment of patients with testicular cancer.
Insights
Advances in testicular cancer treatment have significantly improved outcomes, achieving high cure rates for most patients. However, novel approaches are still needed for the 10% of metastatic cases that remain incurable.
Area of Science:
- Oncology
- Medical Research
Background:
- Testicular cancer treatment has seen remarkable progress due to global research collaboration.
- Significant advancements address localized, retroperitoneal, and advanced metastatic disease stages.
Purpose of the Study:
- To review past and recent discoveries in testicular cancer treatment.
- To highlight progress and remaining challenges in managing testicular cancer.
Main Methods:
- Review of collaborative research efforts and clinical investigations.
- Analysis of treatment strategies including chemotherapy, surgery, and supportive care.
Main Results:
- Cure rates now reach 95% for all testicular cancer patients and 80% for metastatic cases.
- Established optimal chemotherapy regimens, dosing, and surgical techniques.
Conclusions:
- Current treatments offer high cure rates but 10% of metastatic testicular cancer patients remain incurable.
- Novel treatment strategies are essential for refractory metastatic testicular cancer.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...

